CHM.CN Waverunner Capital (CNQ) up 900% to C$0.05 on 08 Jan 2026: watch liquidity
CHM.CN stock surged 900.00% to C$0.05 on 08 Jan 2026 during market hours on the CNQ exchange in Canada, driven by heavy, irregular trading after a low prior close of C$0.01. This price jump lifted Waverunner Capital Inc.’s market cap to about C$37,211,650.00 on conditional volume and a very small free float. The move signals short-term speculative interest and liquidity stress rather than a clear fundamental shift in the healthcare venture firm.
Price action and high-volume moves for CHM.CN stock
The key fact: CHM.CN stock moved from a previous close of C$0.01 to C$0.05, a C$0.04 change equal to 900.00% on 08 Jan 2026. Average daily volume is modest at 28,908 shares, so a block trade or concentrated orders can produce outsized percentage swings. Year range sits between C$0.05 and C$0.10, so current levels remain below the 52-week high but well above the immediate prior session.
Drivers behind the CHM.CN stock spike
One likely driver is speculative trading around the company’s rebrand from Chemistree Technology to Waverunner Capital in June 2024 and repositioning into venture investments. Another driver is the stock’s tiny per-share price and large share count of 744,233,000 outstanding, which increases volatility. There is no confirmed new public filing or earnings release tied to the jump; investors should verify corporate disclosures at the company site.
Fundamental snapshot: CHM.CN financials and valuation
Waverunner Capital reports EPS: -0.01 and a negative PE shown as -5.00, reflecting losses and limited operating revenue. Key balance metrics include book value per share: -0.11 and cash per share C$0.01, while the current ratio is 0.16, signaling tight short-term liquidity. Market-cap-to-share metrics show a small-cap profile at C$37,211,650.00, which compares unfavorably to sector peers in Healthcare on CNQ.
Trading metrics and technicals for CHM.CN stock
Short-term averages show a 50-day price average at C$0.04 and a 200-day average at C$0.05, placing the current price slightly above the 50-day mean. Average volume of 28,908 contrasts with the session’s outsized activity, implying low liquidity and high slippage risk. Traders should note the extreme percent change and limited bid depth when sizing positions.
Meyka AI rating and CHM.CN stock forecast
Meyka AI rates CHM.CN with a score out of 100: 65.15 / Grade B — HOLD. This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus. Meyka AI’s forecast model projects a 12-month mid-point price of C$0.07, implying an upside of 40.00% versus the current C$0.05, but forecasts are model-based projections and not guarantees.
Risks, catalysts and trading strategy for CHM.CN stock
Primary risks are limited liquidity, negative working capital (-C$390,427.00) and the company’s small-cap status in the Healthcare sector. Catalysts would include formal investment announcements, audited financial improvements, or strategic M&A. For high-volume mover strategies, we recommend strict size limits, limit orders, and monitoring filings on SEDAR plus the company site.
Final Thoughts
CHM.CN stock’s 900.00% jump to C$0.05 on 08 Jan 2026 is a clear high-volume mover event on the CNQ exchange in Canada driven by low float and concentrated trading rather than transparent fundamental news. Financially, Waverunner Capital reports an EPS of -0.01, negative book value per share, and a current ratio of 0.16, all of which argue for caution. Meyka AI rates CHM.CN 65.15 (Grade B — HOLD) and models a 12-month forecast of C$0.07, an implied 40.00% upside from today’s price; forecasts are projections and not guarantees. Short-term traders can find momentum opportunities but face high slippage and volatility; longer-term investors should wait for clearer financial improvements or confirmed corporate catalysts. For real-time filings and company updates see the Waverunner Capital website and check our CHM.CN page for live metrics at Meyka stock page. Meyka AI provides this AI-powered market analysis as informational content, not investment advice.
FAQs
Why did CHM.CN stock spike 900% on 08 Jan 2026?
The spike reflected concentrated trading in a low-priced, thinly traded stock, not a clear earnings or regulatory announcement. Low float and a small average volume of 28,908 shares can produce outsized percentage moves.
What is Meyka AI’s view on CHM.CN stock?
Meyka AI rates CHM.CN 65.15 / Grade B — HOLD and projects a 12-month target of C$0.07, implying 40.00% upside, with a clear caveat that forecasts are model-based and not guarantees.
What fundamental risks should investors watch for CHM.CN stock?
Key risks are negative book value per share (-0.11), low cash per share (C$0.01), poor current ratio (0.16), and limited operating cash flows, all of which heighten liquidity and solvency concerns.
How should traders approach CHM.CN stock after this high-volume move?
Traders should use limit orders, set tight position sizes, and watch order book depth. Confirm any corporate filings before adding exposure because slippage and fast reversals are common.
Disclaimer:
Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.
